12:00 AM
May 07, 2012
 |  BC Week In Review  |  Company News  |  Other News

Pfizer, Brigham Young University neurology, autoimmune news

Pfizer said it reached an "amicable" agreement with the university to settle a 2006 suit in the U.S. District Court for the District of Utah related to Celebrex celecoxib, a cyclooxygenase-2 (COX-2) inhibitor. As part of the settlement, the university will establish a Dan Simmons Chair. Simmons is a professor in the Department of Chemistry and Biochemistry at...

Read the full 287 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >